V. Caillard

发表

Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels

J. Baron, H. Cambon, J. Martinot, 2004, Psychopharmacology.

Plasmodium vinckei petteri: identification of the stages sensitive to arteether.

V. Caillard, I. Landau, A. Chabaud, 1992, Experimental parasitology.

Stage sensitivity of Plasmodium vinckei petteri to quinine, mefloquine, and pyrimethamine.

H. Ginsburg, V. Caillard, I. Landau, 1995, The Journal of parasitology.

Targets for neurotransmitter receptor research using PET scan: the neuroleptic binding site.

J. Baron, H. Cambon, J. Martinot, 1989, Psychopharmacology series.

Schizophrenia: a study of genetic models.

J. Stewart, V. Caillard, Q. Debray, 1979, Human Heredity.

Substantial rise in sparteine metabolic ratio during haloperidol treatment.

É. Zarifian, J. Boulenger, L. Gram, 1989, British journal of clinical pharmacology.

Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.

J. Baron, B. Mazoyer, J. Martinot, 1990, The American journal of psychiatry.

Sertraline in the Prevention of Depression

V. Caillard, D. Doogan, 1992, British Journal of Psychiatry.

Schizophrenia: a study of genetic models and some of their implications.

J. Stewart, V. Caillard, Q. Debray, 1978, Neuropsychobiology.

Schizophrenia: the testing of genetic models by pedigree analysis.

J. Stewart, V. Caillard, Q. Debray, 1980, American journal of human genetics.

A randomized, placebo-controlled trial of sertraline for prophylactic treatment of highly recurrent major depressive disorder.

J. Lépine, P. Boyer, J. Bisserbe, 2004, The American journal of psychiatry.

Sertraline: a new antidepressant.

V. Caillard, D. Doogan, 1988, The Journal of clinical psychiatry.

Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double‐blind controlled study

F. Rouillon, V. Caillard, S. Markabi, 1999, Acta psychiatrica Scandinavica.

Chronotherapy of malaria: identification of drug-sensitive stage of parasite and timing of drug delivery for improved therapy.

H. Ginsburg, G. Cambiè, V. Caillard, 1991, Annales de parasitologie humaine et comparee.

The chemotherapy of rodent malaria. LIII. 'Fenozan B07' (Fenozan-50F), a difluorinated 3,3'-spirocyclopentane 1,2,4-trioxane: comparison with some compounds of the artemisinin series.

S. Fleck, V. Caillard, W. Peters, 1997, Annals of tropical medicine and parasitology.

QUININE, MEFLOQUINE, AND PYRIMETHAMINE

H. Ginsburg, V. Caillard, I. Landau, 1995 .

Reboxetine, a New Noradrenaline Selective Antidepressant, Is at Least as Effective as Fluoxetine in the Treatment of Depression

J. Rybakowski, M. Versiani, V. Caillard, 2002, Journal of clinical psychopharmacology.

Compared Efficacy of Prazepam and Clomipramine in Major Depression with Anxiety: a Multicenter Controlled Study

J. Boulenger, J. Boulenger, P. Lemoine, 1991, Pharmacopsychiatry.

Treatment of mania using a calcium antagonist--preliminary trial.

V. Caillard, 1985, Neuropsychobiology.

Open clinical study of cis(Z)‐clopenthixol

D. Sechter, V. Caillard, H. Cuche, 1981, Acta psychiatrica Scandinavica. Supplementum.

Striatal D2 dopaminergic receptor status ascertained in vivo by positron emission tomography and 76Br-bromospiperone in untreated schizophrenics

B. Mazoyer, J. Martinot, H. Lôo, 1989, Psychiatry Research.